Intracellular processing of epidermal growth factor and its effect on ligand-receptor interactions
- PMID: 2985587
Intracellular processing of epidermal growth factor and its effect on ligand-receptor interactions
Abstract
When normal human fibroblasts are brought to a steady state with 125I-labeled epidermal growth factor (125I-EGF), greater than 90% of the radioactivity is intracellular. We investigated this material to determine whether the 125I-EGF is intact or degraded. Our results show that 125I-EGF is rapidly processed after internalization and can be resolved into four peaks by native gel electrophoresis. These different forms were isolated and tested for their ability to bind to cell-surface EGF receptors. The first processed form was fully capable of binding to EGF receptors, but the second processed form could not. The third form was a collection of small degradation products. We calculated that at steady state about 60% of internalized "125I-EGF" was in a form still able to bind to EGF receptors. We then investigated the ability of different reported inhibitors of EGF "degradation" to block the processing of EGF. Although inhibitors of cathepsin B (leupeptin, antipain, N alpha-p-tosyl-L-lysine chloromethyl ketone, and chymostatin) were able to inhibit the release of monoiodotyrosine from treated cells in a time- and concentration-dependent manner, they had little effect on the processing step that apparently inactivates 125I-EGF. In contrast, agents that raised intravesicular pH, such as methylamine and monensin, inhibited the initial steps in EGF processing as well as the later steps. Low temperatures inhibited the transfer of 125I-EGF to the lysosomes and inhibited the conversion of EGF to a nonbindable form, but had little effect on the initial processing. We conclude that the intracellular processing of EGF is a multistep process that is initiated prior to lysosomal fusion, involves cathepsin B activity, and requires an acidic pH. In addition, many of the protease inhibitors that have been utilized to investigate the role of EGF degradation in mitogenesis do not block the conversion of EGF to a form that is apparently unable to interact with its receptor.
Similar articles
-
Monensin, like methylamine, prevents degradation of 125I-epidermal growth factor, causes intracellular accumulation of receptors and blocks the mitogenic response.Biochem Biophys Res Commun. 1984 Oct 30;124(2):585-91. doi: 10.1016/0006-291x(84)91594-8. Biochem Biophys Res Commun. 1984. PMID: 6093806
-
Receptor-bound somatostatin and epidermal growth factor are processed differently in GH4C1 rat pituitary cells.J Cell Biol. 1986 Mar;102(3):878-88. doi: 10.1083/jcb.102.3.878. J Cell Biol. 1986. PMID: 2869047 Free PMC article.
-
The processing of receptor-bound [125I-Tyr11]somatostatin by RINm5F insulinoma cells.J Biol Chem. 1986 Mar 15;261(8):3571-7. J Biol Chem. 1986. PMID: 2869033
-
Role of intracellular degradation of epidermal growth factor in mitogenesis.Exp Cell Res. 1982 Nov;142(1):111-7. doi: 10.1016/0014-4827(82)90415-3. Exp Cell Res. 1982. PMID: 6982826
-
Intracellular modification of 125I-labeled epidermal growth factor by normal human foreskin fibroblasts.Endocrinology. 1986 Feb;118(2):875-82. doi: 10.1210/endo-118-2-875. Endocrinology. 1986. PMID: 2867893
Cited by
-
Transepithelial transport of epidermal growth factor by absorptive cells of suckling rat ileum.J Clin Invest. 1987 Jul;80(1):22-32. doi: 10.1172/JCI113051. J Clin Invest. 1987. PMID: 3496363 Free PMC article.
-
Degradation of atrial natriuretic factor in the rat.Biochem J. 1986 Dec 1;240(2):461-9. doi: 10.1042/bj2400461. Biochem J. 1986. PMID: 2949739 Free PMC article.
-
Uptake and metabolic fate of [HisA8,HisB4,GluB10,HisB27]insulin in rat liver in vivo.Biochem J. 1998 Jun 1;332 ( Pt 2)(Pt 2):421-30. doi: 10.1042/bj3320421. Biochem J. 1998. PMID: 9601071 Free PMC article.
-
Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking.Mol Biol Cell. 2001 Jun;12(6):1897-910. doi: 10.1091/mbc.12.6.1897. Mol Biol Cell. 2001. PMID: 11408594 Free PMC article.
-
STAT3 and STAT6 Signaling Pathways Synergize to Promote Cathepsin Secretion from Macrophages via IRE1α Activation.Cell Rep. 2016 Sep 13;16(11):2914-2927. doi: 10.1016/j.celrep.2016.08.035. Cell Rep. 2016. PMID: 27626662 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources